These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28636713)

  • 61. Accuracy and Interobserver Variability in Reporting of PI-RADS Version 2.
    Flood TF; Pokharel SS; Patel NU; Clark TJ
    J Am Coll Radiol; 2017 Sep; 14(9):1202-1205. PubMed ID: 28571670
    [No Abstract]   [Full Text] [Related]  

  • 62. Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.
    Pang K; Fitch M; Ouellet V; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; So A; Sutcliffe S; Tanguay S; Saad F; Mes-Masson AM
    BMC Health Serv Res; 2018 Jun; 18(1):430. PubMed ID: 29884180
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patterns of care for prostate cancer treatment and improving outcomes - are national registries the answer?
    O'Callaghan M; Papa N; Pase M; Frydenberg M; Mark S; Moretti K; Maqsood S; Smith D; Walker T; White C; Millar J;
    BJU Int; 2021 Oct; 128 Suppl 1():6-8. PubMed ID: 33977631
    [No Abstract]   [Full Text] [Related]  

  • 64. Prevalence of complementary medicine in urologic practice. A review of recent studies with emphasis on use among prostate cancer patients.
    Zimmerman RA; Thompson IM
    Urol Clin North Am; 2002 Feb; 29(1):1-9, vii. PubMed ID: 12109336
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Screening for important unwarranted variation in clinical practice: a triple-test of processes of care, costs and patient outcomes.
    Partington A; Chew DP; Ben-Tovim D; Horsfall M; Hakendorf P; Karnon J
    Aust Health Rev; 2017 Mar; 41(1):104-110. PubMed ID: 26934081
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.
    Gómez Caamaño A; Zapatero A; López Torrecilla J; Maldonado X
    Clin Transl Oncol; 2016 Sep; 18(9):884-92. PubMed ID: 26621508
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Profile of the rural surgeon.
    Traverso LW
    Surg Endosc; 2008 Jul; 22(7):1586-8. PubMed ID: 18506526
    [No Abstract]   [Full Text] [Related]  

  • 68. Evolution of primary care referrals to urology. Impact of a protocol on prostate disease and continuing education.
    Sopeña-Sutil R; Tejido-Sánchez A; Galván-Ortiz de Urbina M; Guerrero-Ramos F; García-Álvarez G; Passas-Martínez JB
    Actas Urol Esp; 2015 Jun; 39(5):296-302. PubMed ID: 25554605
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?
    Booth CM; Karim S; Brennan K; Siemens DR; Peng Y; Mackillop WJ
    Urol Oncol; 2018 Mar; 36(3):89.e13-89.e20. PubMed ID: 29254673
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy.
    Schwartz MJ; Hwang DH; Hung AJ; Han J; McClain JW; Shemtov MM; Te AE; Sosa RE; Vaughan ED; Scherr DS
    Cancer; 2008 Apr; 112(8):1718-25. PubMed ID: 18330908
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.
    Pickles K; Carter SM; Rychetnik L
    BMJ Open; 2015 Mar; 5(3):e006367. PubMed ID: 25783420
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ERCP and fluoroscopy time.
    Alkhatib AA; Jalil AA; Harrison ME
    Am J Gastroenterol; 2014 Mar; 109(3):447-8. PubMed ID: 24594961
    [No Abstract]   [Full Text] [Related]  

  • 73. Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer.
    Liu J; Womble PR; Merdan S; Miller DC; Montie JE; Denton BT;
    Urology; 2015 Nov; 86(5):901-5. PubMed ID: 26358397
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Response to Alkhatib et al.
    Romagnuolo J
    Am J Gastroenterol; 2014 Mar; 109(3):448. PubMed ID: 24594963
    [No Abstract]   [Full Text] [Related]  

  • 75. Use of surveillance data in developing geographic dissemination strategies: a study of the diffusion of olanzapine to Michigan children insured by medicaid.
    Penfold RB; Kelleher KJ
    Clin Ther; 2007 Feb; 29(2):359-70; discussion 358. PubMed ID: 17472829
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Frequency and focus of sexual history taking in male patients--a pilot study conducted among Swiss general practitioners and urologists.
    Platano G; Margraf J; Alder J; Bitzer J
    J Sex Med; 2008 Jan; 5(1):47-59. PubMed ID: 17956557
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Retrospective Analysis of a Consolidation of Urology Practices, and the Resulting Physician Productivity in the Provision of Urologic Care.
    Roehmholdt MJ
    J Med Pract Manage; 2016 Nov; 32(3):164-168. PubMed ID: 29944811
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
    Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
    Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Primary physicians and adolescent health care.
    Pratt HD; Phillips EL; Patel DR; Tong DD
    Psychiatr Serv; 1998 Apr; 49(4):537. PubMed ID: 9550252
    [No Abstract]   [Full Text] [Related]  

  • 80. Commentary on: "Satisfaction with information used to choose prostate cancer treatment." Gilbert SM, Sanda MG, Dunn RL, Greenfield TK, Hembroff L, Klein E, Saigal CS, Pisters L, Michalski J, Sandler HM, Litwin MS, Wei JT. H. Lee Moffitt Cancer Center, Tampa, Florida; Department of Urology, Emory University, Atlanta, Georgia; Department of Urology, University of Michigan, Ann Arbor, Michigan; Department of Psychiatry and Public Health Institute, University of California-San Francisco, California; Institute for Public Policy and Social Research, Michigan State University, Lansing, Michigan; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio; Department of Urology and Department of Health Policy and Management, University of California-Los Angeles, Los Angeles, California; Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.: J Urol 2014;191(5):1265-71. doi:10.1016/j.juro.2013.12.008. [Epub 2013 Dec 12].
    Brent H
    Urol Oncol; 2016 May; 34(5):247-8. PubMed ID: 25990613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.